Although we observed no change in Epac1 levels in hippocampal postmortem samples of AD patients, an upregulation of Epac1 mRNA was previously reported in frontal cortex postmortem samples of AD patients [41]. This evidence concerns the gene RAPGEF3 and Alzheimer disease.